Spots Global Cancer Trial Database for high grade serous carcinoma
Every month we try and update this database with for high grade serous carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| Combination of Olaparib and Navitoclax in Women With HGSC and TNBC | NCT05358639 | High Grade Sero... Triple Negative... Ovarian Cancer | Olaparib tablet Navitoclax | 18 Years - | Sunnybrook Health Sciences Centre | |
| Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma | NCT05537844 | Ovarian Cancer High Grade Sero... Carcinosarcoma,... Fallopian Tube ... Primary Periton... BRCA1 Mutation BRCA2 Mutation | 16 Years - | Cancer Research UK, Glasgow | ||
| A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) | NCT03824704 | Epithelial Ovar... Fallopian Tube ... Primary Periton... High Grade Sero... Endometrioid Ad... | Rucaparib Nivolumab | 18 Years - | pharmaand GmbH | |
| Role of the ATP7A Transporter in Ovarian Cancer | NCT05490407 | Gynecologic Can... Ovarian Cancer High Grade Sero... Chemotherapy Ef... | Carboplatin | 18 Years - 80 Years | University Medical Centre Ljubljana | |
| Combination of Olaparib and Navitoclax in Women With HGSC and TNBC | NCT05358639 | High Grade Sero... Triple Negative... Ovarian Cancer | Olaparib tablet Navitoclax | 18 Years - | Sunnybrook Health Sciences Centre | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer | NCT05080556 | Ovarian Cancer Relapsed Ovaria... Fallopian Tube ... Peritoneal Canc... Endometrioid Ca... High Grade Sero... Ovary Cancer | Carboplatin | 18 Years - | University College, London | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer | NCT03462342 | High Grade Sero... | Olaparib Pill AZD6738 | 18 Years - | University of Pennsylvania | |
| Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma | NCT05537844 | Ovarian Cancer High Grade Sero... Carcinosarcoma,... Fallopian Tube ... Primary Periton... BRCA1 Mutation BRCA2 Mutation | 16 Years - | Cancer Research UK, Glasgow | ||
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy | NCT03593681 | Fallopian Tube ... Ovarian Cancer Ovarian Neoplas... Ovary Cancer Fallopian Tube ... Fallopian Tube ... High Grade Sero... Peritoneal Carc... Peritoneal Neop... Adnexal Mass Ovarian Disease... | Hysteroscopic c... | 18 Years - | Boston Scientific Corporation | |
| A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) | NCT03824704 | Epithelial Ovar... Fallopian Tube ... Primary Periton... High Grade Sero... Endometrioid Ad... | Rucaparib Nivolumab | 18 Years - | pharmaand GmbH | |
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Combination of Olaparib and Navitoclax in Women With HGSC and TNBC | NCT05358639 | High Grade Sero... Triple Negative... Ovarian Cancer | Olaparib tablet Navitoclax | 18 Years - | Sunnybrook Health Sciences Centre |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
